"Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia"
"Conclusions and Relevance In this preliminary 10-week phase 2 randomized clinical trial of patients with probable Alzheimer disease, combination dextromethorphan-quinidine demonstrated clinically relevant efficacy for agitation and was generally well tolerated."
http://jama.jamanetwork.com/article.aspx?articleid=2442936
No comments:
Post a Comment